Significance of magnesium in congestive heart failure (Q41107593)

26 September 2017

1 reference

title

Significance of magnesium in congestive heart failure (English)

1 reference

26 September 2017

0 references

congestive heart failure

1 reference

Douban S

1

1 reference

26 September 2017

Brodsky MA

series ordinal

2

1 reference

26 September 2017

Whang DD

series ordinal

3

1 reference

26 September 2017

Whang R

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

26 September 2017

American Heart Journal

1 reference

26 September 2017

132

1 reference

26 September 2017

3

1 reference

26 September 2017

664-671

1 reference

Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium Deficiency in Patients on Long-Term Diuretic Therapy for Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

EFFECTS OF CARDIAC GLYCOSIDES ON RENAL TUBULAR TRANSPORT OF CALCIUM, MAGNESIUM, INORGANIC PHOSPHATE, AND GLUCOSE IN THE DOG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium homeostasis and clinical disorders of magnesium deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Renal adaptation to the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium deficiency in a medical ICU population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Observations in experimental magnesium depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Modulation of cardiac ion channels by magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Myocardial K kinetics in rats on Mg-deficient diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium: Nature's physiologic calcium blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium ions in cardiac function. Regulator of ion channels and second messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Serum Magnesium and Potassium in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Frequency of hypomagnesemia in hospitalized patients receiving digitalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of aldosterone on the metabolism of magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Studies of the Acute Effects of Aldosterone and Cortisol on the Interrelationship Between Renal Sodium, Calcium and Magnesium Excretion in Normal Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Electrolyte disturbances in chronic heart failure: metabolic and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Prognostic importance of the serum magnesium concentration in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Low blood mononuclear cell magnesium in intensive cardiac care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium and lipids in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Hypomagnesemia and hypokalemia in 1,000 treated ambulatory hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Variant angina due to deficiency of intracellular magnesium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Reduction of pacing-induced myocardial ischemia by intravenous magnesium sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Endomyocardial fibrosis--the possible connexion with myocardial levels of magnesium and cerium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium and potassium therapy in multifocal atrial tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Multifocal atrial tachycardia from electrolyte imbalance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium deficiency and cardiac disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in a nondigitalized noncardiac patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium deficiency contributing to ventricular tachycardia. Two case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Hypomagnesemic torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Is hypomagnesemia or magnesium deficiency arrhythmogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Is hypomagnesemia arrhythmogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Digitalis toxicity and hypomagnesemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Correlation of serum magnesium levels and cardiac digitalis intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium deficiency: pathogenesis, prevalence, and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium and its therapeutic uses: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Hemodynamic effects of magnesium sulfate on the normal human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of magnesium sulfate on cardiovascular hemodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

The effects of magnesium upon cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of intravenous magnesium sulfate on supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium therapy in new-onset atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

The effectiveness of magnesium chloride in the treatment of ventricular tachyarrhythmias due to digitalis intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of magnesium chloride on electrical stability of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium therapy for torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Treatment of torsade de pointes with magnesium sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Inducible monomorphic sustained ventricular tachycardia in the conscious pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effects of low potassium or magnesium concentrations on isolated cardiac tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Magnesium deficiency and refractioriness to potassium repletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990253-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(96)90253-7

1 reference

26 September 2017

1 reference